Healthcare Sector Articles Healthcare Sector Articles - Page 2 August 1, 2026 6:40 AM ETGE HealthCare Stock Climbs on Vital Diagnostics DemandJeffrey Neal JohnsonNASDAQ:GEHCRead GE HealthCare Stock Climbs on Vital Diagnostics DemandJuly 31, 2026 9:00 AM ETMcKesson's Compounding Keeps Adding UpPeter FrankNYSE:MCKNYSE:CAHNYSE:CORRead McKesson's Compounding Keeps Adding UpJuly 30, 2026 5:25 AM ETUnitedHealth Just Gave Wall Street a Clearer Turnaround SignalPeter FrankNYSE:UNHNYSE:HUMNYSE:CVSRead UnitedHealth Just Gave Wall Street a Clearer Turnaround SignalJuly 27, 2026 7:55 AM ETInnovative ETF Strategies That Are Paying Off This SummerNathan ReiffNYSEARCA:BBCNASDAQ:FMEDNYSE:VRead Innovative ETF Strategies That Are Paying Off This SummerJuly 20, 2026 7:40 AM ET3 Medical Device Stocks Giving Investors a Different Healthcare PlayNathan ReiffNYSE:GMEDNYSE:INSPNYSE:PENRead 3 Medical Device Stocks Giving Investors a Different Healthcare PlayJuly 18, 2026 6:15 AM ETWhy Intuitive Surgical’s Strong Quarter Still Spooked InvestorsChris MarkochNASDAQ:ISRGRead Why Intuitive Surgical’s Strong Quarter Still Spooked InvestorsJuly 16, 2026 11:45 AM ETWhy Abbott Laboratories Stock Is Suddenly Winning Back Wall StreetThomas HughesNYSE:ABTRead Why Abbott Laboratories Stock Is Suddenly Winning Back Wall StreetJuly 15, 2026 12:20 PM ETWhy Johnson & Johnson’s Earnings Dip Looks Like a Buying OpportunityThomas HughesNYSE:JNJRead Why Johnson & Johnson’s Earnings Dip Looks Like a Buying OpportunityJuly 15, 2026 8:55 AM ET3 Small-Cap Stocks Trading Under $10 With Room to RunBridget BennettNASDAQ:AVAHNASDAQ:EGANNASDAQ:ACTRead 3 Small-Cap Stocks Trading Under $10 With Room to RunJuly 13, 2026 11:35 AM ETWhy Welltower's Growth Story Might Outrun Its Rich ValuationChris MarkochNYSE:WELLNYSE:VTRRead Why Welltower's Growth Story Might Outrun Its Rich ValuationJuly 13, 2026 6:35 AM ET3 Overlooked Stocks Positioned for the Next Market RotationBridget BennettNYSE:AFLNASDAQ:LGNNASDAQ:LGNDRead 3 Overlooked Stocks Positioned for the Next Market RotationJuly 8, 2026 7:05 AM ETVertex’s Crinetics Deal Balances Growth with Integration RiskChris MarkochNASDAQ:VRTXNASDAQ:CRNXRead Vertex’s Crinetics Deal Balances Growth with Integration RiskJuly 7, 2026 10:25 AM ETAbivax: Wall Street Catches Up to the DataChris MarkochNASDAQ:ABVXNYSE:ABBVRead Abivax: Wall Street Catches Up to the DataJuly 6, 2026 12:20 PM ETAs Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the WinnerJessica MitacekNYSE:HIMSNYSE:NVONYSE:LLYRead As Employers Drop Obesity Drug Coverage, Hims & Hers Could Be the Winner Page 2 of 2 ‹ Most Recent12 More Articles by TopicArticle TopicsAll ArticlesAIAnalyst RatingsBiotechCommunication Services SectorCongressional TradingConsumer Discretionary SectorConsumer Staples SectorDefenseDividendEarningsElectric VehicleEnergy SectorETFFinance SectorHealthcare SectorIndustrial SectorInsider TradingInvestor EducationIPOMacroMaterials SectorMergers & AcquisitionsQuantum ComputingRare Earth MineralsReal Estate SectorSemiconductorShort InterestSpaceStock IdeaStock MarketTechnology SectorUtilities SectorInstant Alert TopicsAll Instant AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
